author-photo

Jeremy Jones

City of Hope National Medical Center

75

Papers

1524

Citations

Citation Trend

Filter By

Papers (51) Sort By

Journal Conference Others

Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy

2019 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (23)
Higher Rates of Pseudoprogression Among Pediatric Low-Grade Glioma Patients Treated with Proton versus Photon Radiotherapy

2019 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (0)
Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High‐Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial

2018 Oncologist
Show All
- Source
- Cite
- Save
Citations (4)
Gut microbiome composition and response to sunitinib in metastatic renal cell carcinoma (mRCC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC)

2018 Cancer
Show All
- Source
- Cite
- Save
Citations (30)
Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma

2018 European Urology
Show All
- Source
- Cite
- Save
Citations (31)
Exceptional Response to Nivolumab Rechallenge in Metastatic Renal Cell Carcinoma with Parallel Changes in Genomic Profile

2018 European Urology
Show All
- Source
- Cite
- Save
Citations (9)
Association of microbiome and plasma cytokine dynamics to nivolumab response in metastatic renal cell carcinoma (mRCC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma

2017 European Urology
Show All
- Source
- Cite
- Save
Citations (72)
Abstract LB-058: ABIraterone (ABI) and ENZalutamide (ENZ) induce changes in immunologic profile of patients with metastatic castration-resistant prostate cancer (mCRPC)

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)